HRA006607
Title:
Uncovering the molecular pathways associated with immunotherapy-induced pneumonitis in non-small cell lung cancer patients
Release date:
2025-06-30
Description:
In this project, the experimental group was the immune checkpoint inhibitor-related pneumonitis(CIP) tissue samples of advanced non-small cell lung cancer patients after receiving immunotherapy treatment. We comprehensively analyzed the immune landscape during CIP onset using scRNA/TCR/BCR-seq, it could serve as a novel therapeutic strategy for CIP treatment and provide biomarkers and intervention targets for precision medicine.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
postinflammatory pulmonary fibrosis
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
CIP Data Access Committee
Contact person:
Lin Xinqing
Email:
linxinqing81@163.com
Description:
It is used to collect the information of the data management committee, and log in the system to complete the request review in time.
Individuals & samples
Submitter:   Lin Xinqing / linxinqing81@163.com
Organization:   The First Affiliated Hospital of Guangzhou Medical University
Submission date:   2024-01-24
Requests:   7